Smart Inhalers
Due to the COVID-19 pandemic, the global Smart Inhalers market size is estimated to be worth US$ ... Read More
Global Inhalers Market Research Report 2023
1 Inhalers Market Overview
1.1 Product Overview and Scope of Inhalers
1.2 Inhalers Segment by Type
1.2.1 Global Inhalers Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Metered Dose Inhalers
1.2.3 Dry Powder Inhalers
1.2.4 Nasal Inhalers
1.2.5 Other
1.3 Inhalers Segment by Application
1.3.1 Global Inhalers Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Respiratory Care Centers
1.3.5 Others
1.4 Global Inhalers Market Size Estimates and Forecasts
1.4.1 Global Inhalers Revenue 2017-2028
1.4.2 Global Inhalers Sales 2017-2028
1.4.3 Inhalers Market Size by Region: 2017 Versus 2021 Versus 2028
2 Inhalers Market Competition by Manufacturers
2.1 Global Inhalers Sales Market Share by Manufacturers (2017-2022)
2.2 Global Inhalers Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Inhalers Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Inhalers Manufacturing Sites, Area Served, Product Type
2.5 Inhalers Market Competitive Situation and Trends
2.5.1 Inhalers Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Inhalers Players Market Share by Revenue
2.5.3 Global Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhalers Retrospective Market Scenario by Region
3.1 Global Inhalers Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Inhalers Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Inhalers Market Facts & Figures by Country
3.3.1 North America Inhalers Sales by Country
3.3.2 North America Inhalers Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Inhalers Market Facts & Figures by Country
3.4.1 Europe Inhalers Sales by Country
3.4.2 Europe Inhalers Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Inhalers Market Facts & Figures by Region
3.5.1 Asia Pacific Inhalers Sales by Region
3.5.2 Asia Pacific Inhalers Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Inhalers Market Facts & Figures by Country
3.6.1 Latin America Inhalers Sales by Country
3.6.2 Latin America Inhalers Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Inhalers Market Facts & Figures by Country
3.7.1 Middle East and Africa Inhalers Sales by Country
3.7.2 Middle East and Africa Inhalers Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Inhalers Historic Market Analysis by Type
4.1 Global Inhalers Sales Market Share by Type (2017-2022)
4.2 Global Inhalers Revenue Market Share by Type (2017-2022)
4.3 Global Inhalers Price by Type (2017-2022)
5 Global Inhalers Historic Market Analysis by Application
5.1 Global Inhalers Sales Market Share by Application (2017-2022)
5.2 Global Inhalers Revenue Market Share by Application (2017-2022)
5.3 Global Inhalers Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GlaxoSmithKline Inhalers Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Merck Inhalers Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.3.4 AstraZeneca Inhalers Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Boehringer-Ingelheim
6.4.1 Boehringer-Ingelheim Corporation Information
6.4.2 Boehringer-Ingelheim Description and Business Overview
6.4.3 Boehringer-Ingelheim Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Boehringer-Ingelheim Inhalers Product Portfolio
6.4.5 Boehringer-Ingelheim Recent Developments/Updates
6.5 3M
6.5.1 3M Corporation Information
6.5.2 3M Description and Business Overview
6.5.3 3M Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.5.4 3M Inhalers Product Portfolio
6.5.5 3M Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Teva Inhalers Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Sunovion Pharmaceuticals
6.6.1 Sunovion Pharmaceuticals Corporation Information
6.6.2 Sunovion Pharmaceuticals Description and Business Overview
6.6.3 Sunovion Pharmaceuticals Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sunovion Pharmaceuticals Inhalers Product Portfolio
6.7.5 Sunovion Pharmaceuticals Recent Developments/Updates
6.8 Aristopharma
6.8.1 Aristopharma Corporation Information
6.8.2 Aristopharma Description and Business Overview
6.8.3 Aristopharma Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Aristopharma Inhalers Product Portfolio
6.8.5 Aristopharma Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Novartis Inhalers Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Vectura Group
6.10.1 Vectura Group Corporation Information
6.10.2 Vectura Group Description and Business Overview
6.10.3 Vectura Group Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Vectura Group Inhalers Product Portfolio
6.10.5 Vectura Group Recent Developments/Updates
6.11 MannKind
6.11.1 MannKind Corporation Information
6.11.2 MannKind Inhalers Description and Business Overview
6.11.3 MannKind Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.11.4 MannKind Inhalers Product Portfolio
6.11.5 MannKind Recent Developments/Updates
6.12 Respirices
6.12.1 Respirices Corporation Information
6.12.2 Respirices Inhalers Description and Business Overview
6.12.3 Respirices Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Respirices Inhalers Product Portfolio
6.12.5 Respirices Recent Developments/Updates
6.13 Orion Pharm
6.13.1 Orion Pharm Corporation Information
6.13.2 Orion Pharm Inhalers Description and Business Overview
6.13.3 Orion Pharm Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Orion Pharm Inhalers Product Portfolio
6.13.5 Orion Pharm Recent Developments/Updates
6.14 Hovione
6.14.1 Hovione Corporation Information
6.14.2 Hovione Inhalers Description and Business Overview
6.14.3 Hovione Inhalers Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Hovione Inhalers Product Portfolio
6.14.5 Hovione Recent Developments/Updates
7 Inhalers Manufacturing Cost Analysis
7.1 Inhalers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Inhalers
7.4 Inhalers Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Inhalers Distributors List
8.3 Inhalers Customers
9 Inhalers Market Dynamics
9.1 Inhalers Industry Trends
9.2 Inhalers Market Drivers
9.3 Inhalers Market Challenges
9.4 Inhalers Market Restraints
10 Global Market Forecast
10.1 Inhalers Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Inhalers by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Inhalers by Type (2023-2028)
10.2 Inhalers Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Inhalers by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Inhalers by Application (2023-2028)
10.3 Inhalers Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Inhalers by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Inhalers by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Inhalers Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Inhalers Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Inhalers Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Inhalers Market Competitive Situation by Manufacturers in 2021
Table 5. Global Inhalers Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Inhalers Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Inhalers Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Inhalers Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Inhalers Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Inhalers Manufacturing Sites and Area Served
Table 11. Manufacturers Inhalers Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Inhalers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhalers as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Inhalers Sales by Region (2017-2022) & (K Units)
Table 16. Global Inhalers Sales Market Share by Region (2017-2022)
Table 17. Global Inhalers Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Inhalers Revenue Market Share by Region (2017-2022)
Table 19. North America Inhalers Sales by Country (2017-2022) & (K Units)
Table 20. North America Inhalers Sales Market Share by Country (2017-2022)
Table 21. North America Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Inhalers Revenue Market Share by Country (2017-2022)
Table 23. Europe Inhalers Sales by Country (2017-2022) & (K Units)
Table 24. Europe Inhalers Sales Market Share by Country (2017-2022)
Table 25. Europe Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Inhalers Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Inhalers Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Inhalers Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Inhalers Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Inhalers Revenue Market Share by Region (2017-2022)
Table 31. Latin America Inhalers Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Inhalers Sales Market Share by Country (2017-2022)
Table 33. Latin America Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Inhalers Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Inhalers Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Inhalers Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Inhalers Revenue Market Share by Country (2017-2022)
Table 39. Global Inhalers Sales by Type (2017-2022) & (K Units)
Table 40. Global Inhalers Sales Market Share by Type (2017-2022)
Table 41. Global Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Inhalers Revenue Share by Type (2017-2022)
Table 43. Global Inhalers Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Inhalers Sales (K Units) by Application (2017-2022)
Table 45. Global Inhalers Sales Market Share by Application (2017-2022)
Table 46. Global Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Inhalers Revenue Share by Application (2017-2022)
Table 48. Global Inhalers Price by Application (2017-2022) & (USD/Unit)
Table 49. GlaxoSmithKline Corporation Information
Table 50. GlaxoSmithKline Description and Business Overview
Table 51. GlaxoSmithKline Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. GlaxoSmithKline Inhalers Product
Table 53. GlaxoSmithKline Recent Developments/Updates
Table 54. Merck Corporation Information
Table 55. Merck Description and Business Overview
Table 56. Merck Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Merck Inhalers Product
Table 58. Merck Recent Developments/Updates
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Description and Business Overview
Table 61. AstraZeneca Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. AstraZeneca Inhalers Product
Table 63. AstraZeneca Recent Developments/Updates
Table 64. Boehringer-Ingelheim Corporation Information
Table 65. Boehringer-Ingelheim Description and Business Overview
Table 66. Boehringer-Ingelheim Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Boehringer-Ingelheim Inhalers Product
Table 68. Boehringer-Ingelheim Recent Developments/Updates
Table 69. 3M Corporation Information
Table 70. 3M Description and Business Overview
Table 71. 3M Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. 3M Inhalers Product
Table 73. 3M Recent Developments/Updates
Table 74. Teva Corporation Information
Table 75. Teva Description and Business Overview
Table 76. Teva Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Teva Inhalers Product
Table 78. Teva Recent Developments/Updates
Table 79. Sunovion Pharmaceuticals Corporation Information
Table 80. Sunovion Pharmaceuticals Description and Business Overview
Table 81. Sunovion Pharmaceuticals Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Sunovion Pharmaceuticals Inhalers Product
Table 83. Sunovion Pharmaceuticals Recent Developments/Updates
Table 84. Aristopharma Corporation Information
Table 85. Aristopharma Description and Business Overview
Table 86. Aristopharma Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Aristopharma Inhalers Product
Table 88. Aristopharma Recent Developments/Updates
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Business Overview
Table 91. Novartis Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Novartis Inhalers Product
Table 93. Novartis Recent Developments/Updates
Table 94. Vectura Group Corporation Information
Table 95. Vectura Group Description and Business Overview
Table 96. Vectura Group Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Vectura Group Inhalers Product
Table 98. Vectura Group Recent Developments/Updates
Table 99. MannKind Corporation Information
Table 100. MannKind Description and Business Overview
Table 101. MannKind Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. MannKind Inhalers Product
Table 103. MannKind Recent Developments/Updates
Table 104. Respirices Corporation Information
Table 105. Respirices Description and Business Overview
Table 106. Respirices Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Respirices Inhalers Product
Table 108. Respirices Recent Developments/Updates
Table 109. Orion Pharm Corporation Information
Table 110. Orion Pharm Description and Business Overview
Table 111. Orion Pharm Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Orion Pharm Inhalers Product
Table 113. Orion Pharm Recent Developments/Updates
Table 114. Hovione Corporation Information
Table 115. Hovione Description and Business Overview
Table 116. Hovione Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Hovione Inhalers Product
Table 118. Hovione Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Inhalers Distributors List
Table 122. Inhalers Customers List
Table 123. Inhalers Market Trends
Table 124. Inhalers Market Drivers
Table 125. Inhalers Market Challenges
Table 126. Inhalers Market Restraints
Table 127. Global Inhalers Sales Forecast by Type (2023-2028) & (K Units)
Table 128. Global Inhalers Sales Market Share Forecast by Type (2023-2028)
Table 129. Global Inhalers Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 130. Global Inhalers Revenue Market Share Forecast by Type (2023-2028)
Table 131. Global Inhalers Sales Forecast by Application (2023-2028) & (K Units)
Table 132. Global Inhalers Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Inhalers Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Inhalers Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Inhalers Sales Forecast by Region (2023-2028) & (K Units)
Table 136. Global Inhalers Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Inhalers Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Inhalers Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inhalers
Figure 2. Global Inhalers Market Share by Type in 2021 & 2028
Figure 3. Metered Dose Inhalers Product Picture
Figure 4. Dry Powder Inhalers Product Picture
Figure 5. Nasal Inhalers Product Picture
Figure 6. Other Product Picture
Figure 7. Global Inhalers Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Respiratory Care Centers
Figure 11. Others
Figure 12. Global Inhalers Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Inhalers Market Size (2017-2028) & (US$ Million)
Figure 14. Global Inhalers Sales (2017-2028) & (K Units)
Figure 15. Inhalers Sales Share by Manufacturers in 2021
Figure 16. Global Inhalers Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Inhalers Players: Market Share by Revenue in 2021
Figure 18. Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Inhalers Sales Market Share by Region (2017-2022)
Figure 20. Global Inhalers Sales Market Share by Region in 2021
Figure 21. Global Inhalers Revenue Market Share by Region (2017-2022)
Figure 22. Global Inhalers Revenue Market Share by Region in 2021
Figure 23. U.S. Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. UAE Inhalers Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Inhalers by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Inhalers
Figure 49. Manufacturing Process Analysis of Inhalers
Figure 50. Inhalers Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline Merck AstraZeneca Boehringer-Ingelheim 3M Teva Sunovion Pharmaceuticals Aristopharma Novartis Vectura Group MannKind Respirices Orion Pharm Hovione